img

Global Morphine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Morphine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Morphine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Morphine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Morphine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Morphine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Morphine include Mallinckrodt Pharmaceuticals, Alcaliber, Purdue Pharma, Sanofi Winthrop Industrie, Macfarlan Smith, Sun Pharmaceutical Industries, Qinghai Pharmaceutical and Northeast Pharmaceutical Group, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Morphine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Morphine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Morphine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Morphine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Mallinckrodt Pharmaceuticals
Alcaliber
Purdue Pharma
Sanofi Winthrop Industrie
Macfarlan Smith
Sun Pharmaceutical Industries
Qinghai Pharmaceutical
Northeast Pharmaceutical Group
By Type
Oral Tablets
Injection
Capsule
Others
By Application
Anesthesia
Cough Suppressant
Diarrhea Suppressant
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Morphine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Morphine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Morphine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Morphine Definition
1.2 Market by Type
1.2.1 Global Morphine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral Tablets
1.2.3 Injection
1.2.4 Capsule
1.2.5 Others
1.3 Market Segment by Application
1.3.1 Global Morphine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Anesthesia
1.3.3 Cough Suppressant
1.3.4 Diarrhea Suppressant
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Morphine Sales
2.1 Global Morphine Revenue Estimates and Forecasts 2018-2034
2.2 Global Morphine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Morphine Revenue by Region
2.3.1 Global Morphine Revenue by Region (2018-2024)
2.3.2 Global Morphine Revenue by Region (2024-2034)
2.4 Global Morphine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Morphine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Morphine Sales Quantity by Region
2.6.1 Global Morphine Sales Quantity by Region (2018-2024)
2.6.2 Global Morphine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Morphine Sales Quantity by Manufacturers
3.1.1 Global Morphine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Morphine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Morphine Sales in 2022
3.2 Global Morphine Revenue by Manufacturers
3.2.1 Global Morphine Revenue by Manufacturers (2018-2024)
3.2.2 Global Morphine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Morphine Revenue in 2022
3.3 Global Morphine Sales Price by Manufacturers
3.4 Global Key Players of Morphine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Morphine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Morphine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Morphine, Product Offered and Application
3.8 Global Key Manufacturers of Morphine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Morphine Sales Quantity by Type
4.1.1 Global Morphine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Morphine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Morphine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Morphine Revenue by Type
4.2.1 Global Morphine Historical Revenue by Type (2018-2024)
4.2.2 Global Morphine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Morphine Revenue Market Share by Type (2018-2034)
4.3 Global Morphine Price by Type
4.3.1 Global Morphine Price by Type (2018-2024)
4.3.2 Global Morphine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Morphine Sales Quantity by Application
5.1.1 Global Morphine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Morphine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Morphine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Morphine Revenue by Application
5.2.1 Global Morphine Historical Revenue by Application (2018-2024)
5.2.2 Global Morphine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Morphine Revenue Market Share by Application (2018-2034)
5.3 Global Morphine Price by Application
5.3.1 Global Morphine Price by Application (2018-2024)
5.3.2 Global Morphine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Morphine Sales by Company
6.1.1 North America Morphine Revenue by Company (2018-2024)
6.1.2 North America Morphine Sales Quantity by Company (2018-2024)
6.2 North America Morphine Market Size by Type
6.2.1 North America Morphine Sales Quantity by Type (2018-2034)
6.2.2 North America Morphine Revenue by Type (2018-2034)
6.3 North America Morphine Market Size by Application
6.3.1 North America Morphine Sales Quantity by Application (2018-2034)
6.3.2 North America Morphine Revenue by Application (2018-2034)
6.4 North America Morphine Market Size by Country
6.4.1 North America Morphine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Morphine Revenue by Country (2018-2034)
6.4.3 North America Morphine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Morphine Sales by Company
7.1.1 Europe Morphine Sales Quantity by Company (2018-2024)
7.1.2 Europe Morphine Revenue by Company (2018-2024)
7.2 Europe Morphine Market Size by Type
7.2.1 Europe Morphine Sales Quantity by Type (2018-2034)
7.2.2 Europe Morphine Revenue by Type (2018-2034)
7.3 Europe Morphine Market Size by Application
7.3.1 Europe Morphine Sales Quantity by Application (2018-2034)
7.3.2 Europe Morphine Revenue by Application (2018-2034)
7.4 Europe Morphine Market Size by Country
7.4.1 Europe Morphine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Morphine Revenue by Country (2018-2034)
7.4.3 Europe Morphine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Morphine Sales by Company
8.1.1 China Morphine Sales Quantity by Company (2018-2024)
8.1.2 China Morphine Revenue by Company (2018-2024)
8.2 China Morphine Market Size by Type
8.2.1 China Morphine Sales Quantity by Type (2018-2034)
8.2.2 China Morphine Revenue by Type (2018-2034)
8.3 China Morphine Market Size by Application
8.3.1 China Morphine Sales Quantity by Application (2018-2034)
8.3.2 China Morphine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Morphine Sales by Company
9.1.1 APAC Morphine Sales Quantity by Company (2018-2024)
9.1.2 APAC Morphine Revenue by Company (2018-2024)
9.2 APAC Morphine Market Size by Type
9.2.1 APAC Morphine Sales Quantity by Type (2018-2034)
9.2.2 APAC Morphine Revenue by Type (2018-2034)
9.3 APAC Morphine Market Size by Application
9.3.1 APAC Morphine Sales Quantity by Application (2018-2034)
9.3.2 APAC Morphine Revenue by Application (2018-2034)
9.4 APAC Morphine Market Size by Region
9.4.1 APAC Morphine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Morphine Revenue by Region (2018-2034)
9.4.3 APAC Morphine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Morphine Sales by Company
10.1.1 Middle East, Africa and Latin America Morphine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Morphine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Morphine Market Size by Type
10.2.1 Middle East, Africa and Latin America Morphine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Morphine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Morphine Market Size by Application
10.3.1 Middle East, Africa and Latin America Morphine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Morphine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Morphine Market Size by Country
10.4.1 Middle East, Africa and Latin America Morphine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Morphine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Morphine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Mallinckrodt Pharmaceuticals
11.1.1 Mallinckrodt Pharmaceuticals Company Information
11.1.2 Mallinckrodt Pharmaceuticals Overview
11.1.3 Mallinckrodt Pharmaceuticals Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Mallinckrodt Pharmaceuticals Morphine Products and Services
11.1.5 Mallinckrodt Pharmaceuticals Morphine SWOT Analysis
11.1.6 Mallinckrodt Pharmaceuticals Recent Developments
11.2 Alcaliber
11.2.1 Alcaliber Company Information
11.2.2 Alcaliber Overview
11.2.3 Alcaliber Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Alcaliber Morphine Products and Services
11.2.5 Alcaliber Morphine SWOT Analysis
11.2.6 Alcaliber Recent Developments
11.3 Purdue Pharma
11.3.1 Purdue Pharma Company Information
11.3.2 Purdue Pharma Overview
11.3.3 Purdue Pharma Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Purdue Pharma Morphine Products and Services
11.3.5 Purdue Pharma Morphine SWOT Analysis
11.3.6 Purdue Pharma Recent Developments
11.4 Sanofi Winthrop Industrie
11.4.1 Sanofi Winthrop Industrie Company Information
11.4.2 Sanofi Winthrop Industrie Overview
11.4.3 Sanofi Winthrop Industrie Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Sanofi Winthrop Industrie Morphine Products and Services
11.4.5 Sanofi Winthrop Industrie Morphine SWOT Analysis
11.4.6 Sanofi Winthrop Industrie Recent Developments
11.5 Macfarlan Smith
11.5.1 Macfarlan Smith Company Information
11.5.2 Macfarlan Smith Overview
11.5.3 Macfarlan Smith Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Macfarlan Smith Morphine Products and Services
11.5.5 Macfarlan Smith Morphine SWOT Analysis
11.5.6 Macfarlan Smith Recent Developments
11.6 Sun Pharmaceutical Industries
11.6.1 Sun Pharmaceutical Industries Company Information
11.6.2 Sun Pharmaceutical Industries Overview
11.6.3 Sun Pharmaceutical Industries Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Sun Pharmaceutical Industries Morphine Products and Services
11.6.5 Sun Pharmaceutical Industries Morphine SWOT Analysis
11.6.6 Sun Pharmaceutical Industries Recent Developments
11.7 Qinghai Pharmaceutical
11.7.1 Qinghai Pharmaceutical Company Information
11.7.2 Qinghai Pharmaceutical Overview
11.7.3 Qinghai Pharmaceutical Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Qinghai Pharmaceutical Morphine Products and Services
11.7.5 Qinghai Pharmaceutical Morphine SWOT Analysis
11.7.6 Qinghai Pharmaceutical Recent Developments
11.8 Northeast Pharmaceutical Group
11.8.1 Northeast Pharmaceutical Group Company Information
11.8.2 Northeast Pharmaceutical Group Overview
11.8.3 Northeast Pharmaceutical Group Morphine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Northeast Pharmaceutical Group Morphine Products and Services
11.8.5 Northeast Pharmaceutical Group Morphine SWOT Analysis
11.8.6 Northeast Pharmaceutical Group Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Morphine Value Chain Analysis
12.2 Morphine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Morphine Production Mode & Process
12.4 Morphine Sales and Marketing
12.4.1 Morphine Sales Channels
12.4.2 Morphine Distributors
12.5 Morphine Customers
13 Market Dynamics
13.1 Morphine Industry Trends
13.2 Morphine Market Drivers
13.3 Morphine Market Challenges
13.4 Morphine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Morphine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oral Tablets
Table 3. Major Manufacturers of Injection
Table 4. Major Manufacturers of Capsule
Table 5. Major Manufacturers of Others
Table 6. Global Morphine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Morphine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 8. Global Morphine Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Morphine Revenue Market Share by Region (2018-2024)
Table 10. Global Morphine Revenue by Region (2024-2034) & (US$ Million)
Table 11. Global Morphine Revenue Market Share by Region (2024-2034)
Table 12. Global Morphine Sales Quantity by Region: 2018 VS 2022 VS 2034 (Kiloton)
Table 13. Global Morphine Sales by Region (2018-2024) & (Kiloton)
Table 14. Global Morphine Sales Market Share by Region (2018-2024)
Table 15. Global Morphine Sales by Region (2024-2034) & (Kiloton)
Table 16. Global Morphine Sales Market Share by Region (2024-2034)
Table 17. Global Morphine Sales Quantity by Manufacturers (2018-2024) & (Kiloton)
Table 18. Global Morphine Sales Quantity Share by Manufacturers (2018-2024)
Table 19. Global Morphine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Morphine Revenue Share by Manufacturers (2018-2024)
Table 21. Global Morphine Price by Manufacturers 2018-2024 (US$/Ton)
Table 22. Global Key Players of Morphine, Industry Ranking, 2021 VS 2022
Table 23. Global Morphine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Morphine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Morphine as of 2022)
Table 25. Global Key Manufacturers of Morphine, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Morphine, Product Offered and Application
Table 27. Global Key Manufacturers of Morphine, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Morphine Sales Quantity by Type (2018-2024) & (Kiloton)
Table 30. Global Morphine Sales Quantity by Type (2024-2034) & (Kiloton)
Table 31. Global Morphine Sales Quantity Share by Type (2018-2024)
Table 32. Global Morphine Sales Quantity Share by Type (2024-2034)
Table 33. Global Morphine Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Morphine Revenue by Type (2024-2034) & (US$ Million)
Table 35. Global Morphine Revenue Share by Type (2018-2024)
Table 36. Global Morphine Revenue Share by Type (2024-2034)
Table 37. Morphine Price by Type (2018-2024) & (US$/Ton)
Table 38. Global Morphine Price Forecast by Type (2024-2034) & (US$/Ton)
Table 39. Global Morphine Sales Quantity by Application (2018-2024) & (Kiloton)
Table 40. Global Morphine Sales Quantity by Application (2024-2034) & (Kiloton)
Table 41. Global Morphine Sales Quantity Share by Application (2018-2024)
Table 42. Global Morphine Sales Quantity Share by Application (2024-2034)
Table 43. Global Morphine Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Morphine Revenue by Application (2024-2034) & (US$ Million)
Table 45. Global Morphine Revenue Share by Application (2018-2024)
Table 46. Global Morphine Revenue Share by Application (2024-2034)
Table 47. Morphine Price by Application (2018-2024) & (US$/Ton)
Table 48. Global Morphine Price Forecast by Application (2024-2034) & (US$/Ton)
Table 49. North America Morphine Revenue by Company (2018-2024) & (US$ Million)
Table 50. North America Morphine Sales Quantity by Company (2018-2024) & (Kiloton)
Table 51. North America Morphine Sales Quantity by Type (2018-2024) & (Kiloton)
Table 52. North America Morphine Sales Quantity by Type (2024-2034) & (Kiloton)
Table 53. North America Morphine Revenue by Type (2018-2024) & (US$ Million)
Table 54. North America Morphine Revenue by Type (2024-2034) & (US$ Million)
Table 55. North America Morphine Sales Quantity by Application (2018-2024) & (Kiloton)
Table 56. North America Morphine Sales Quantity by Application (2024-2034) & (Kiloton)
Table 57. North America Morphine Revenue by Application (2018-2024) & (US$ Million)
Table 58. North America Morphine Revenue by Application (2024-2034) & (US$ Million)
Table 59. North America Morphine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 60. North America Morphine Revenue by Country (2018-2024) & (US$ Million)
Table 61. North America Morphine Revenue by Country (2024-2034) & (US$ Million)
Table 62. North America Morphine Sales Quantity by Country (2018-2024) & (Kiloton)
Table 63. North America Morphine Sales Quantity by Country (2024-2034) & (Kiloton)
Table 64. Europe Morphine Sales Quantity by Company (2018-2024) & (Kiloton)
Table 65. Europe Morphine Revenue by Company (2018-2024) & (US$ Million)
Table 66. Europe Morphine Sales Quantity by Type (2018-2024) & (Kiloton)
Table 67. Europe Morphine Sales Quantity by Type (2024-2034) & (Kiloton)
Table 68. Europe Morphine Revenue by Type (2018-2024) & (US$ Million)
Table 69. Europe Morphine Revenue by Type (2024-2034) & (US$ Million)
Table 70. Europe Morphine Sales Quantity by Application (2018-2024) & (Kiloton)
Table 71. Europe Morphine Sales Quantity by Application (2024-2034) & (Kiloton)
Table 72. Europe Morphine Revenue by Application (2018-2024) & (US$ Million)
Table 73. Europe Morphine Revenue by Application (2024-2034) & (US$ Million)
Table 74. Europe Morphine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 75. Europe Morphine Revenue by Country (2018-2024) & (US$ Million)
Table 76. Europe Morphine Revenue by Country (2024-2034) & (US$ Million)
Table 77. Europe Morphine Sales Quantity by Country (2018-2024) & (Kiloton)
Table 78. Europe Morphine Sales Quantity by Country (2024-2034) & (Kiloton)
Table 79. China Morphine Sales Quantity by Company (2018-2024) & (Kiloton)
Table 80. China Morphine Revenue by Company (2018-2024) & (US$ Million)
Table 81. China Morphine Sales Quantity by Type (2018-2024) & (Kiloton)
Table 82. China Morphine Sales Quantity by Type (2024-2034) & (Kiloton)
Table 83. China Morphine Revenue by Type (2018-2024) & (US$ Million)
Table 84. China Morphine Revenue by Type (2024-2034) & (US$ Million)
Table 85. China Morphine Sales Quantity by Application (2018-2024) & (Kiloton)
Table 86. China Morphine Sales Quantity by Application (2024-2034) & (Kiloton)
Table 87. China Morphine Revenue by Application (2018-2024) & (US$ Million)
Table 88. China Morphine Revenue by Application (2024-2034) & (US$ Million)
Table 89. APAC Morphine Sales Quantity by Company (2018-2024) & (Kiloton)
Table 90. APAC Morphine Revenue by Company (2018-2024) & (US$ Million)
Table 91. APAC Morphine Sales Quantity by Type (2018-2024) & (Kiloton)
Table 92. APAC Morphine Sales Quantity by Type (2024-2034) & (Kiloton)
Table 93. APAC Morphine Revenue by Type (2018-2024) & (US$ Million)
Table 94. APAC Morphine Revenue by Type (2024-2034) & (US$ Million)
Table 95. APAC Morphine Sales Quantity by Application (2018-2024) & (Kiloton)
Table 96. APAC Morphine Sales Quantity by Application (2024-2034) & (Kiloton)
Table 97. APAC Morphine Revenue by Application (2018-2024) & (US$ Million)
Table 98. APAC Morphine Revenue by Application (2024-2034) & (US$ Million)
Table 99. APAC Morphine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 100. APAC Morphine Revenue by Region (2018-2024) & (US$ Million)
Table 101. APAC Morphine Revenue by Region (2024-2034) & (US$ Million)
Table 102. APAC Morphine Sales Quantity by Region (2018-2024) & (Kiloton)
Table 103. APAC Morphine Sales Quantity by Region (2024-2034) & (Kiloton)
Table 104. Middle East, Africa and Latin America Morphine Sales Quantity by Company (2018-2024) & (Kiloton)
Table 105. Middle East, Africa and Latin America Morphine Revenue by Company (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Morphine Sales Quantity by Type (2018-2024) & (Kiloton)
Table 107. Middle East, Africa and Latin America Morphine Sales Quantity by Type (2024-2034) & (Kiloton)
Table 108. Middle East, Africa and Latin America Morphine Revenue by Type (2018-2024) & (US$ Million)
Table 109. Middle East, Africa and Latin America Morphine Revenue by Type (2024-2034) & (US$ Million)
Table 110. Middle East, Africa and Latin America Morphine Sales Quantity by Application (2018-2024) & (Kiloton)
Table 111. Middle East, Africa and Latin America Morphine Sales Quantity by Application (2024-2034) & (Kiloton)
Table 112. Middle East, Africa and Latin America Morphine Revenue by Application (2018-2024) & (US$ Million)
Table 113. Middle East, Africa and Latin America Morphine Revenue by Application (2024-2034) & (US$ Million)
Table 114. Middle East, Africa and Latin America Morphine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 115. Middle East, Africa and Latin America Morphine Revenue by Country (2018-2024) & (US$ Million)
Table 116. Middle East, Africa and Latin America Morphine Revenue by Country (2024-2034) & (US$ Million)
Table 117. Middle East, Africa and Latin America Morphine Sales Quantity by Country (2018-2024) & (Kiloton)
Table 118. Middle East, Africa and Latin America Morphine Sales Quantity by Country (2024-2034) & (Kiloton)
Table 119. Mallinckrodt Pharmaceuticals Company Information
Table 120. Mallinckrodt Pharmaceuticals Description and Overview
Table 121. Mallinckrodt Pharmaceuticals Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 122. Mallinckrodt Pharmaceuticals Morphine Product and Services
Table 123. Mallinckrodt Pharmaceuticals Morphine SWOT Analysis
Table 124. Mallinckrodt Pharmaceuticals Recent Developments
Table 125. Alcaliber Company Information
Table 126. Alcaliber Description and Overview
Table 127. Alcaliber Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 128. Alcaliber Morphine Product and Services
Table 129. Alcaliber Morphine SWOT Analysis
Table 130. Alcaliber Recent Developments
Table 131. Purdue Pharma Company Information
Table 132. Purdue Pharma Description and Overview
Table 133. Purdue Pharma Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 134. Purdue Pharma Morphine Product and Services
Table 135. Purdue Pharma Morphine SWOT Analysis
Table 136. Purdue Pharma Recent Developments
Table 137. Sanofi Winthrop Industrie Company Information
Table 138. Sanofi Winthrop Industrie Description and Overview
Table 139. Sanofi Winthrop Industrie Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 140. Sanofi Winthrop Industrie Morphine Product and Services
Table 141. Sanofi Winthrop Industrie Morphine SWOT Analysis
Table 142. Sanofi Winthrop Industrie Recent Developments
Table 143. Macfarlan Smith Company Information
Table 144. Macfarlan Smith Description and Overview
Table 145. Macfarlan Smith Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 146. Macfarlan Smith Morphine Product and Services
Table 147. Macfarlan Smith Morphine SWOT Analysis
Table 148. Macfarlan Smith Recent Developments
Table 149. Sun Pharmaceutical Industries Company Information
Table 150. Sun Pharmaceutical Industries Description and Overview
Table 151. Sun Pharmaceutical Industries Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 152. Sun Pharmaceutical Industries Morphine Product and Services
Table 153. Sun Pharmaceutical Industries Morphine SWOT Analysis
Table 154. Sun Pharmaceutical Industries Recent Developments
Table 155. Qinghai Pharmaceutical Company Information
Table 156. Qinghai Pharmaceutical Description and Overview
Table 157. Qinghai Pharmaceutical Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 158. Qinghai Pharmaceutical Morphine Product and Services
Table 159. Qinghai Pharmaceutical Morphine SWOT Analysis
Table 160. Qinghai Pharmaceutical Recent Developments
Table 161. Northeast Pharmaceutical Group Company Information
Table 162. Northeast Pharmaceutical Group Description and Overview
Table 163. Northeast Pharmaceutical Group Morphine Sales Quantity (Kiloton), Revenue (US$ Million), Average Selling Price (ASP) (US$/Ton) and Gross Margin (2018-2024)
Table 164. Northeast Pharmaceutical Group Morphine Product and Services
Table 165. Northeast Pharmaceutical Group Morphine SWOT Analysis
Table 166. Northeast Pharmaceutical Group Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Morphine Distributors List
Table 170. Morphine Customers List
Table 171. Morphine Market Trends
Table 172. Morphine Market Drivers
Table 173. Morphine Market Challenges
Table 174. Morphine Market Restraints
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Morphine Product Picture
Figure 2. Global Morphine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Morphine Market Share by Type in 2022 & 2034
Figure 4. Oral Tablets Product Picture
Figure 5. Injection Product Picture
Figure 6. Capsule Product Picture
Figure 7. Others Product Picture
Figure 8. Global Morphine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 9. Global Morphine Market Share by Application in 2022 & 2034
Figure 10. Anesthesia
Figure 11. Cough Suppressant
Figure 12. Diarrhea Suppressant
Figure 13. Morphine Report Years Considered
Figure 14. Global Morphine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Morphine Revenue 2018-2034 (US$ Million)
Figure 16. Global Morphine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 17. Global Morphine Sales Quantity 2018-2034 (Kiloton)
Figure 18. Global Morphine Sales Quantity Market Share by Region (2018-2024)
Figure 19. Global Morphine Sales Quantity Market Share by Region (2024-2034)
Figure 20. North America Morphine Sales Quantity YoY (2018-2034) & (Kiloton)
Figure 21. North America Morphine Revenue YoY (2018-2034) & (US$ Million)
Figure 22. Europe Morphine Sales Quantity YoY (2018-2034) & (Kiloton)
Figure 23. Europe Morphine Revenue YoY (2018-2034) & (US$ Million)
Figure 24. China Morphine Sales Quantity YoY (2018-2034) & (Kiloton)
Figure 25. China Morphine Revenue YoY (2018-2034) & (US$ Million)
Figure 26. APAC Morphine Sales Quantity YoY (2018-2034) & (Kiloton)
Figure 27. APAC Morphine Revenue YoY (2018-2034) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Morphine Sales Quantity YoY (2018-2034) & (Kiloton)
Figure 29. Middle East, Africa and Latin America Morphine Revenue YoY (2018-2034) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Morphine Sales Quantity in 2022
Figure 31. The Top 10 and Top 5 Players Market Share by Morphine Revenue in 2022
Figure 32. Morphine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Morphine Sales Quantity Market Share by Type (2018-2034)
Figure 34. Global Morphine Revenue Market Share by Type (2018-2034)
Figure 35. Global Morphine Sales Quantity Market Share by Application (2018-2034)
Figure 36. Global Morphine Revenue Market Share by Application (2018-2034)
Figure 37. North America Morphine Revenue Market Share by Company in 2022
Figure 38. North America Morphine Sales Quantity Market Share by Company in 2022
Figure 39. North America Morphine Sales Quantity Market Share by Type (2018-2034)
Figure 40. North America Morphine Revenue Market Share by Type (2018-2034)
Figure 41. North America Morphine Sales Quantity Market Share by Application (2018-2034)
Figure 42. North America Morphine Revenue Market Share by Application (2018-2034)
Figure 43. North America Morphine Revenue Share by Country (2018-2034)
Figure 44. North America Morphine Sales Quantity Share by Country (2018-2034)
Figure 45. U.S. Morphine Revenue (2018-2034) & (US$ Million)
Figure 46. Canada Morphine Revenue (2018-2034) & (US$ Million)
Figure 47. Europe Morphine Sales Quantity Market Share by Company in 2022
Figure 48. Europe Morphine Revenue Market Share by Company in 2022
Figure 49. Europe Morphine Sales Quantity Market Share by Type (2018-2034)
Figure 50. Europe Morphine Revenue Market Share by Type (2018-2034)
Figure 51. Europe Morphine Sales Quantity Market Share by Application (2018-2034)
Figure 52. Europe Morphine Revenue Market Share by Application (2018-2034)
Figure 53. Europe Morphine Revenue Share by Country (2018-2034)
Figure 54. Europe Morphine Sales Quantity Share by Country (2018-2034)
Figure 55. Germany Morphine Revenue (2018-2034) & (US$ Million)
Figure 56. France Morphine Revenue (2018-2034) & (US$ Million)
Figure 57. U.K. Morphine Revenue (2018-2034) & (US$ Million)
Figure 58. Italy Morphine Revenue (2018-2034) & (US$ Million)
Figure 59. Russia Morphine Revenue (2018-2034) & (US$ Million)
Figure 60. China Morphine Sales Quantity Market Share by Company in 2022
Figure 61. China Morphine Revenue Market Share by Company in 2022
Figure 62. China Morphine Sales Quantity Market Share by Type (2018-2034)
Figure 63. China Morphine Revenue Market Share by Type (2018-2034)
Figure 64. China Morphine Sales Quantity Market Share by Application (2018-2034)
Figure 65. China Morphine Revenue Market Share by Application (2018-2034)
Figure 66. APAC Morphine Sales Quantity Market Share by Company in 2022
Figure 67. APAC Morphine Revenue Market Share by Company in 2022
Figure 68. APAC Morphine Sales Quantity Market Share by Type (2018-2034)
Figure 69. APAC Morphine Revenue Market Share by Type (2018-2034)
Figure 70. APAC Morphine Sales Quantity Market Share by Application (2018-2034)
Figure 71. APAC Morphine Revenue Market Share by Application (2018-2034)
Figure 72. APAC Morphine Revenue Share by Region (2018-2034)
Figure 73. APAC Morphine Sales Quantity Share by Region (2018-2034)
Figure 74. Japan Morphine Revenue (2018-2034) & (US$ Million)
Figure 75. South Korea Morphine Revenue (2018-2034) & (US$ Million)
Figure 76. China Taiwan Morphine Revenue (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Morphine Revenue (2018-2034) & (US$ Million)
Figure 78. India Morphine Revenue (2018-2034) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Morphine Sales Quantity Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Morphine Revenue Market Share by Company in 2022
Figure 81. Middle East, Africa and Latin America Morphine Sales Quantity Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Morphine Revenue Market Share by Type (2018-2034)
Figure 83. Middle East, Africa and Latin America Morphine Sales Quantity Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Morphine Revenue Market Share by Application (2018-2034)
Figure 85. Middle East, Africa and Latin America Morphine Sales Quantity Share by Country (2018-2034)
Figure 86. Middle East, Africa and Latin America Morphine Revenue Share by Country (2018-2034)
Figure 87. Brazil Morphine Revenue (2018-2034) & (US$ Million)
Figure 88. Mexico Morphine Revenue (2018-2034) & (US$ Million)
Figure 89. Turkey Morphine Revenue (2018-2034) & (US$ Million)
Figure 90. Israel Morphine Revenue (2018-2034) & (US$ Million)
Figure 91. GCC Countries Morphine Revenue (2018-2034) & (US$ Million)
Figure 92. Morphine Value Chain
Figure 93. Morphine Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed